Prognostic impact of biomarkers in PMBCL: rationale for early integration of immune checkpoint inhibitors by Yana K. Mangasarova, Runiza R. Abdurashidova, Natalya V. Risinskaya, Bella V. Biderman, Tatiana V. Abramova, Vadim L. Surin, Irina A. Shupletsova, Tatiana N. Obukhova, Rasul I. Iusupov, Yulia A. Chabaeva, Aminat U. Magomedova, Lena E. Nikulina, Sergei M. Kulikov, Eugene E. Zvonkov, Alla M. Kovrigina, Andrey B. Sudarikov

Get full text